Stocks of UnitedHealth Group Incorporated (NYSE:UNH) traded higher last session on Wall Street, up 0.74% to $503.70.
According to the data, UnitedHealth Group Incorporated (NYSE:UNH) has 28 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $650.00 and a low of $489.00, we find $565.00. Given the previous closing price of $500.00, this indicates a potential upside of 13.0 percent. UNH stock price is now 4.93% away from the 50-day moving average and 0.95% away from the 200-day moving average. The market capitalization of the company currently stands at $437.30B.
A total of 4 analysts have issued a hold rating and 21 have given it a buy rating. Brokers who have rated the stock have averaged $569.88 as their price target over the next twelve months.
With the price target enhanced from $510 to $520, UBS maintained Neutral rating for UnitedHealth Group Incorporated (NYSE: UNH).
In other news, WITTY ANDREW, CEO, UHG sold 6,160 shares of the company’s stock on Apr 27. The stock was sold for $3,002,949 at an average price of $487.49. Upon completion of the transaction, the CEO, UHG now directly owns 86,564 shares in the company, valued at $43.6 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 25, EVP Chief People Officer McSweeney Erin sold 761 shares of the business’s stock. A total of $376,543 was realized by selling the stock at an average price of $494.80. This leaves the insider owning 9,293 shares of the company worth $4.68 million. Insiders disposed of 271,517 shares of company stock worth roughly $136.76 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in UNH stock. A new stake in UnitedHealth Group Incorporated shares was purchased by OFI INVEST ASSET MANAGEMENT during the first quarter worth $31,253,932,000. FARALLON CAPITAL MANAGEMENT LLC invested $436,204,000 in shares of UNH during the first quarter. In the first quarter, D1 CAPITAL PARTNERS L.P. acquired a new stake in UnitedHealth Group Incorporated valued at approximately $264,946,000. COATUE MANAGEMENT LLC acquired a new stake in UNH for approximately $255,787,000. CANOE FINANCIAL LP purchased a new stake in UNH valued at around $161,575,000 in the second quarter. In total, there are 4,012 active investors with 89.70% ownership of the company’s stock.
Wednesday’s opening bell rang with an opening price of $507.54 for UnitedHealth Group Incorporated (NYSE: UNH). During the past 12 months, UnitedHealth Group Incorporated has had a low of $445.68 and a high of $558.10. According to the stock market information, the enterprise value for the company is $488.27B, which is based on a 23.04 price-to-earnings ratio, a 1.83 price-to-earnings-growth ratio, and a beta of 0.66. The fifty day moving average price for UNH is $480.23 and a two-hundred day moving average price translates $498.93 for the stock.
The latest earnings results from UnitedHealth Group Incorporated (NYSE: UNH) was released for Jun, 2023. According to the Healthcare Plans Company, earnings per share came in at $6.14, beating analysts’ expectations of $5.99 by 0.15. This compares to $5.47 EPS in the same period last year. The net profit margin was 6.00% and return on equity was 26.30% for UNH. The company reported revenue of $92.9 billion for the quarter, compared to $80.33 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.65 percent. For the current quarter, analysts expect UNH to generate $91.2B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 06/27/2023. Investors who held shares on 06/19/2023 were paid a $1.88 dividend. On an annualized basis, this represents a $7.52 dividend and a 1.49% percent yield. There was an ex-dividend date of 06/15/2023 for this dividend. In terms of dividend payout ratio, UNH is presently at 29.80%.
UnitedHealth Group Incorporated(UNH) Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The OptumHealth segment provides care delivery, care management, wellness and consumer engagement, and health financial services for consumers, care delivery systems, providers, employers, payers, and public-sector entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
